Date: October 30, 2026
Board Meeting Outcomes
- The company received trading approval from National Stock Exchange of India Limited and BSE Limited for 82,00,000 equity shares of face value ₹1 each
- The shares were allotted pursuant to conversion of warrants issued to Promoter and Non-Promoter categories on preferential basis
- The allotment was made in terms of Chapter V of SEBI (ICDR) Regulations, 2018
- Trading approval letters were received from both exchanges dated October 29, 2026
- Disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Capital Structure Impact
- Upon receipt of trading approvals, the listed capital of the Company increased to ₹44,79,49,960
- This represents 44,79,49,960 fully paid Equity Shares of ₹1 each
- The 82,00,000 shares represent approximately 18.3% increase in the equity capital base